BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12662006)

  • 1. Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis.
    Schön T; Elias D; Moges F; Melese E; Tessema T; Stendahl O; Britton S; Sundqvist T
    Eur Respir J; 2003 Mar; 21(3):483-8. PubMed ID: 12662006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a food supplement rich in arginine in patients with smear positive pulmonary tuberculosis--a randomised trial.
    Schön T; Idh J; Westman A; Elias D; Abate E; Diro E; Moges F; Kassu A; Ayele B; Forslund T; Getachew A; Britton S; Stendahl O; Sundqvist T
    Tuberculosis (Edinb); 2011 Sep; 91(5):370-7. PubMed ID: 21813328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double-blind, placebo-controlled trial.
    Ralph AP; Waramori G; Pontororing GJ; Kenangalem E; Wiguna A; Tjitra E; Sandjaja ; Lolong DB; Yeo TW; Chatfield MD; Soemanto RK; Bastian I; Lumb R; Maguire GP; Eisman J; Price RN; Morris PS; Kelly PM; Anstey NM
    PLoS One; 2013; 8(8):e70032. PubMed ID: 23967066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy with Mycobacterium vaccae as an addition to chemotherapy for the treatment of pulmonary tuberculosis under difficult conditions in Africa.
    Onyebujoh PC; Abdulmumini T; Robinson S; Rook GA; Stanford JL
    Respir Med; 1995 Mar; 89(3):199-207. PubMed ID: 7746913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized controlled trial of zinc and vitamin A as co-adjuvants for the treatment of pulmonary tuberculosis.
    Lawson L; Thacher TD; Yassin MA; Onuoha NA; Usman A; Emenyonu NE; Shenkin A; Davies PD; Cuevas LE
    Trop Med Int Health; 2010 Dec; 15(12):1481-90. PubMed ID: 20958890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of effect of Withania somnifera as an adjuvant to DOTS in patients of newly diagnosed sputum smear positive pulmonary tuberculosis.
    Kumar R; Rai J; Kajal NC; Devi P
    Indian J Tuberc; 2018 Jul; 65(3):246-251. PubMed ID: 29933868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daily adjunctive therapy with vitamin D
    Bekele A; Gebreselassie N; Ashenafi S; Kassa E; Aseffa G; Amogne W; Getachew M; Aseffa A; Worku A; Raqib R; Agerberth B; Hammar U; Bergman P; Aderaye G; Andersson J; Brighenti S
    J Intern Med; 2018 Sep; 284(3):292-306. PubMed ID: 29696707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of pulmonary tuberculosis in HIV seropositive and seronegative patients in a Northeastern region of Brazil.
    Liberato IR; de Albuquerque Mde F; Campelo AR; de Melo HR
    Rev Soc Bras Med Trop; 2004; 37(1):46-50. PubMed ID: 15042183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fixed-dose combination associated with faster time to smear conversion compared to separate tablets of anti-tuberculosis drugs in patients with poorly controlled diabetes and pulmonary tuberculosis in Qatar.
    Al-Shaer MH; Elewa H; Alkabab Y; Nazer LH; Heysell SK
    BMC Infect Dis; 2018 Aug; 18(1):384. PubMed ID: 30089476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.
    Dorman SE; Johnson JL; Goldberg S; Muzanye G; Padayatchi N; Bozeman L; Heilig CM; Bernardo J; Choudhri S; Grosset JH; Guy E; Guyadeen P; Leus MC; Maltas G; Menzies D; Nuermberger EL; Villarino M; Vernon A; Chaisson RE;
    Am J Respir Crit Care Med; 2009 Aug; 180(3):273-80. PubMed ID: 19406981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homeopathic treatment in addition to standard care in multi drug resistant pulmonary tuberculosis: a randomized, double blind, placebo controlled clinical trial.
    Chand KS; Manchanda RK; Mittal R; Batra S; Banavaliker JN; De I
    Homeopathy; 2014 Apr; 103(2):97-107. PubMed ID: 24685414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of anti-tuberculosis treatment among patients receiving highly active antiretroviral therapy at Vihiga district hospital in 2007.
    Kwange SO; Budambula NL
    Indian J Med Microbiol; 2010; 28(1):21-5. PubMed ID: 20061758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chinese herbal medicine as adjuvant treatment to chemotherapy for multidrug-resistant tuberculosis (MDR-TB): A systematic review of randomised clinical trials.
    Wang M; Guan X; Chi Y; Robinson N; Liu JP
    Tuberculosis (Edinb); 2015 Jul; 95(4):364-72. PubMed ID: 25861717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time to sputum smear and culture conversions in multidrug resistant tuberculosis at University of Gondar Hospital, Northwest Ethiopia.
    Shibabaw A; Gelaw B; Wang SH; Tessema B
    PLoS One; 2018; 13(6):e0198080. PubMed ID: 29944658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Smear-negative' pulmonary tuberculosis in a DOTS programme: poor outcomes in an area of high HIV seroprevalence.
    Hargreaves NJ; Kadzakumanja O; Whitty CJ; Salaniponi FM; Harries AD; Squire SB
    Int J Tuberc Lung Dis; 2001 Sep; 5(9):847-54. PubMed ID: 11573897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for tuberculosis smear non-conversion in Eden district, Western Cape, South Africa, 2007-2013: a retrospective cohort study.
    Mlotshwa M; Abraham N; Beery M; Williams S; Smit S; Uys M; Reddy C; Medina-Marino A
    BMC Infect Dis; 2016 Aug; 16():365. PubMed ID: 27484399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind, placebo-controlled, 1:1 randomized Phase III clinical trial of Immunoxel honey lozenges as an adjunct immunotherapy in 269 patients with pulmonary tuberculosis.
    Batbold U; Butov DO; Kutsyna GA; Damdinpurev N; Grinishina EA; Mijiddorj O; Kovolev ME; Baasanjav K; Butova TS; Sandagdorj M; Batbold O; Tseveendorj A; Chunt E; Zaitzeva SI; Stepanenko HL; Makeeva NI; Mospan IV; Pylypchuk VS; Rowe JL; Nyasulu P; Jirathitikal V; Bain AI; Tarakanovskaya MG; Bourinbaiar AS
    Immunotherapy; 2017 Jan; 9(1):13-24. PubMed ID: 27868466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide production in the exhaled air of patients with pulmonary tuberculosis in relation to HIV co-infection.
    Idh J; Westman A; Elias D; Moges F; Getachew A; Gelaw A; Sundqvist T; Forslund T; Alemu A; Ayele B; Diro E; Melese E; Wondmikun Y; Britton S; Stendahl O; Schön T
    BMC Infect Dis; 2008 Oct; 8():146. PubMed ID: 18950489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.